p. 410−418
2228-7949
Vol.9/No.5
p. 419−427
2228-7949
Vol.9/No.5
p. 428−435
2228-7949
Vol.9/No.5
0.05). Homocysteine decteased significantly in control group (p<0.05). Conclusion: Our results showed no improvement in homocystein levels, antioxidant status and inflammatory biomarkers in T2DM patients after treatment with saffron. ]]>
p. 436−445
2228-7949
Vol.9/No.5
p. 446−453
2228-7949
Vol.9/No.5
p. 454−464
2228-7949
Vol.9/No.5
p. 465−473
2228-7949
Vol.9/No.5
2% (day 0), the mice were treated orally with daily artesunate (36.4 mg/kg/day) (positive control), ethanolic extract (100, 200, and 400 mg/kg/day), and the fractions of water, ethyl acetate and n-hexane (108 mg/kg/day each) for 5 consecutive days (from day 0 to 4). Parasitemia inhibition was observed to determine the antimalarial activity of each type of C. costata extract and fractions. Results: The administration of C. costata leaves ethanolic extract (100, 200, and 400 mg/kg) significantly inhibited the growth of PbA in Balb/C mice (42.66%, 66.2 1% and 80.99 % inhibition, respectively) (p<0.05). Similarly, all C. costata fractions also produced antimalarial activity against PbA with administration of the ethyl acetate fraction presenting the highest activity (79.85 % inhibition). Conclusion: The C. costata leaves showed antimalarial activity against PbA. However, further studies are necessary to elucidate the underlying mechanisms of this effect and the active compounds involved. Our current study revealed that C.costata could be a potential candidate to be used as a new antimalarial drug.]]>
p. 474−481
2228-7949
Vol.9/No.5
p. 482−490
2228-7949
Vol.9/No.5